Long-term Effect of tDCS in Patients With Disorders of Consciousness

NCT ID: NCT03114397

Last Updated: 2022-11-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

62 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-09-01

Study Completion Date

2021-12-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this multicentric double-blind sham controlled study, the investigators plan to assess the effects of 20 sessions of tDCS on long-term behavioral recovery in patients with disorders of consciousness. Neurophysiological outcomes (EEG) will also be collected.

This research will 1) determine whether long-term behavioral recovery can be promoted with tDCS and 2) generate knowledge regarding the impact of tDCS on neurophysiological outcome (i.e., EEG) in severely brain injured patients. The investigators will compare the effects of active and sham tDCS on behavioral assessments and quantitative EEG in patients with severe brain injury and its potential application in rehabilitation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Disorder of Consciousness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

anodal stimulation

Patients will receive anodal tDCS (on the left dorsolateral prefrontal cortex) every day for 4 weeks, 5 days per week (tDCS of 2mA during 20minutes) for a total of 20 sessions.

Group Type ACTIVE_COMPARATOR

transcranial direct current stimulation - active

Intervention Type DEVICE

transcranial direct current stimulation will be applied over the left dorsolateral at 2 mA for 20minutes.

sham stimulation

Patients will receive sham tDCS (on the left dorsolateral prefrontal cortex) every day for 4 weeks, 5 days per week (tDCS of 2mA during 20minutes) for a total of 20 sessions.

Group Type PLACEBO_COMPARATOR

transcranial direct current stimulation - sham

Intervention Type DEVICE

transcranial direct current stimulation will be applied over the left dorsolateral at 2 mA for 20minutes. The sham intervention consists of 30 seconds of stimulation at the beginning and the end of the 20minutes of intervention.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

transcranial direct current stimulation - active

transcranial direct current stimulation will be applied over the left dorsolateral at 2 mA for 20minutes.

Intervention Type DEVICE

transcranial direct current stimulation - sham

transcranial direct current stimulation will be applied over the left dorsolateral at 2 mA for 20minutes. The sham intervention consists of 30 seconds of stimulation at the beginning and the end of the 20minutes of intervention.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* CNS medication stable for at least a week
* Stable diagnosis (no diagnosis change based on 2 CRS-R performed within 1 week).
* Between 3 and 24 months post injury
* Structural MRI or CT-scan (to evidence focal lesions on the left DLPFC)

Exclusion Criteria

* Craniotomies encompassing the frontal region (electrodes location)
* VPS under the stimulated area (prefrontal cortex)
* Pacemaker
* Metallic cerebral implant
* Severe medical conditions that might influence clinical diagnosis and EEG activity (e.g., severe hepatic insufficiency or renal failure, or sub-continuous or abundant epileptiform discharges on standard EEG recordings).
Minimum Eligible Age

16 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondazione Salvatore Maugeri, Italy

UNKNOWN

Sponsor Role collaborator

Université Catholique de Louvain, Belgium

UNKNOWN

Sponsor Role collaborator

Hospitales Nisa, Spain

UNKNOWN

Sponsor Role collaborator

I.R.C.C.S. Fondazione Santa Lucia, Italy

UNKNOWN

Sponsor Role collaborator

Schoen Clinic Bad Aibling, Germany

UNKNOWN

Sponsor Role collaborator

Research Center of Neurology, Russia

OTHER_GOV

Sponsor Role collaborator

Therapiezentrum Burgau, Germany

UNKNOWN

Sponsor Role collaborator

pavlov state medical university, Russia

UNKNOWN

Sponsor Role collaborator

Azienda Unita Sanitaria Locale di Piacenza, Italy

UNKNOWN

Sponsor Role collaborator

University of Liege

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aurore Thibaut

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Liege

Liège, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

References

Explore related publications, articles, or registry entries linked to this study.

Thibaut A, Wannez S, Donneau AF, Chatelle C, Gosseries O, Bruno MA, Laureys S. Controlled clinical trial of repeated prefrontal tDCS in patients with chronic minimally conscious state. Brain Inj. 2017;31(4):466-474. doi: 10.1080/02699052.2016.1274776. Epub 2017 Mar 10.

Reference Type BACKGROUND
PMID: 28281845 (View on PubMed)

Thibaut A, Bruno MA, Ledoux D, Demertzi A, Laureys S. tDCS in patients with disorders of consciousness: sham-controlled randomized double-blind study. Neurology. 2014 Apr 1;82(13):1112-8. doi: 10.1212/WNL.0000000000000260. Epub 2014 Feb 26.

Reference Type BACKGROUND
PMID: 24574549 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014/113b

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

tDCS in MCS: Repeated Stimulations
NCT02019615 COMPLETED NA